Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasodilators in acute heart failure.

Steven M Hollenberg1

  • 1Division of Cardiovascular Disease, Cooper University Hospital, One Cooper Plaza, 366 Dorrance, Camden, NJ 08103, USA. Hollenberg-Steven@cooperhealth.edu

Heart Failure Reviews
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same author

Septic cardiomyopathy: a form of myocardial hibernation?

European heart journal·2025
Same author

The Heart in Overdrive, the Mind in Doubt.

Critical care medicine·2025
Same author

Association of noradrenaline dose with mortality in critically ill patients: a systematic review and dose-response meta-analysis.

Critical care (London, England)·2025
Same author

Reversible Myocardial Depression and Dilatation in COVID-19 Shock Patients.

Critical care explorations·2025
Same author

Cardiac patients in intensive care unit research: an urgent call for inclusion.

European heart journal. Acute cardiovascular care·2025

Vasodilators effectively manage acute heart failure symptoms and hemodynamics by reducing left ventricular filling pressure. Available agents like nitroglycerin and nitroprusside offer benefits but require careful monitoring for side effects and potential toxicity.

Area of Science:

  • Cardiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Acute heart failure often presents with elevated left ventricular filling pressure and normal to high blood pressure.
  • Vasodilator therapy is a cornerstone in managing acute heart failure, improving hemodynamics and symptoms.
  • Diuretics are commonly used alongside vasodilators, with loop diuretics potentially exerting venodilatory effects.

Purpose of the Study:

  • To review current vasodilator agents used in acute heart failure.
  • To discuss the mechanisms of action, benefits, and adverse effects of available vasodilators.
  • To provide guidance on the appropriate use of vasodilators in acute heart failure management.

Main Methods:

  • Review of currently available vasodilator agents: nitroglycerin, nitroprusside, and nesiritide.

Related Experiment Videos

  • Discussion of their hemodynamic effects, including venodilation and arterial vasodilation.
  • Analysis of associated adverse effects, potential complications, and contraindications.

    • Main Results:

    • Nitroglycerin primarily causes venodilation, relieving pulmonary congestion and potentially improving myocardial ischemia.
    • Nitroprusside offers balanced arterial and venous vasodilation, aiding in afterload reduction but posing risks of hypotension and toxicity.
    • Nesiritide (B-type natriuretic peptide) acts as a vasodilator but has shown potential for renal function impairment and decreased survival in meta-analyses.

    Conclusions:

    • Vasodilators are crucial in acute heart failure, but agent selection and administration require careful consideration of patient factors and potential risks.
    • Nitrates and nitroprusside have established roles, while nesiritide's use is tempered by safety concerns pending further clinical trials.
    • Angiotensin-converting enzyme inhibitors may be used cautiously for afterload reduction, and calcium antagonists are generally not recommended.